COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,609 Articles (22,913 medRxiv, 8,696 bioRxiv)

Most recent first Previous |  Page 279: Articles 2781-2790  | Next

Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV
Chao, C. W., Sprouse, K. R., Miranda, M. C., Catanzaro, N. J., Hubbard, M. L., Addetia, A., Stewart, C., Brown, J. T., Dosey, A., Valdez, A., Ravichandran, R., Hendricks, G. G., Ahlrichs, M., Dobbins, C., Hand, A., Treichel, C., Willoughby, I., Walls, A. C., McGuire, A. T., Leaf, E. M., Baric, R. S., Schaefer, A., Veesler, D., King, N. P.
10.1101/2024.03.13.584735 — Posted: 2024-03-14
Potential associations of selected polymorphic genetic variants with COVID-19 disease susceptibility and severity
Mozner, O., Szabo, E., Kulin, A., Varady, G., Moldvay, J., Vass, V., Szentesi, A., Janosi, A., Hegyi, P., Sarkadi, B.
10.1101/2024.03.13.24304197 — Posted: 2024-03-14
Engineered Migrasomes: A Robust, Thermally Stable Vaccination Platform
Wang, D., Wang, H., Wan, W., Zhu, Z., Sho, T., Zheng, Y., Zhang, X., Dou, L., Ding, Q., Yu, L., Liu, Z.
10.1101/2024.03.13.584850 — Posted: 2024-03-14
CircRNA-Pro: A Novel Toolkit for High-Precision Detection of Differentially Expressed Circular RNAs and Translatable Circular RNAs
Song, W., Yu, L., Ye, T., Zhang, H., Wang, Y., Yang, Y., Shen, D., Piao, W., Jin, H.
10.1101/2024.03.13.584785 — Posted: 2024-03-14
Mutability and hypermutation antagonize immunoglobulin codon optimality
McGrath, J. J., Park, J., Troxell, C. A., Chervin, J. C., Li, L., Kent, J. R., Changrob, S., Fu, Y., Huang, M., Zheng, N.-Y., Wilbanks, G. D., Nelson, S. A., Sun, J., Inghirami, G., Madariaga, M. L. L., Georgiou, G., Wilson, P. C.
10.1101/2024.03.13.584690 — Posted: 2024-03-14
The association between prolonged SARS-CoV-2 symptoms and work outcomes
Venkatesh, A., Yu, H., Malicki, C., Gottlieb, M., Elmore, J. G., Hill, M. J., Idris, A. H., Montoy, J. C. C., O'Laughlin, K. N., Rising, K. L., Stephens, K. A., Spatz, E. S., Weinstein, R. A., the INSPIRE Group
10.1101/2024.03.10.24304054 — Posted: 2024-03-13
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variant JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study
de Prost, N., Audureau, E., Guillon, A., Handala, L., Preau, S., Guigon, A., Uhel, F., Le Hingrat, Q., Delamaire, F., Grolhier, C., Tamion, F., Moisan, A., Darreau, C., Thomin, J., Contou, D., Henry, A., Daix, T., Hantz, S., Saccheri, C., Giordanengo, V., Pham, T., Chaghouri, A., Bay, P., Pawlotsky, J., Fourati, S.
10.1101/2024.03.11.24304075 — Posted: 2024-03-13
Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study
Moor, J., Toepfner, N., von Meissner, W. C. G., Berner, R., Moor, M. B., Kublickiene, K., Strumann, C., Chao, C.-M.
10.1101/2024.03.08.24303999 — Posted: 2024-03-13
Preoperative COVID-19 Vaccination is Associated with Decreased Perioperative Mortality after Major Vascular Surgery
Ratner, M., Garg, K., Chang, H., Nigalaye, A., Medvedovsky, S., Jacobowitz, G., Siracuse, J. J., Patel, V. I., Schermerhorn, M. L., DiMaggio, C., Rockman, C.
10.1101/2024.03.11.24304133 — Posted: 2024-03-13
SARS-CoV-2 methyltransferase nsp10-16 in complex with natural and drug-like purine analogs for guiding structure-based drug discovery
Kremling, V., Falke, S., Fernandez-Garcia, Y., Ehrt, C., Kiene, A., Klopprogge, B., Scheer, T. E. S., Barthels, F., Middendorf, P., Kuehn, S., Guenther, S., Rarey, M., Chapman, H. N., Oberthuer, D., Sprenger, J.
10.1101/2024.03.13.583470 — Posted: 2024-03-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).